Shareholders' Equity

6 Months Ended

Jun. 30, 2024

Stockholders' Equity Note [Abstract]

Shareholders' Equity

17. Shareholders’ Equity

In May 2019, the Company’s Board of Directors approved a Common Stock repurchase authorization for which there was remaining authority to repurchase 4,109,419 shares of Common Stock as of May 3, 2022. On May 3, 2022, the Board of Directors increased the Common Stock repurchase authorization by 7,890,581 shares to 12,000,000 shares as of that date. As of June 30, 2024, the Company had remaining authority to repurchase 10,820,689 shares of Common Stock.

Changes to the Company's common shares outstanding were as follows (in shares):

	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023
Outstanding at beginning of period		65,475,989			65,378,771			65,473,807			65,472,148
Repurchases of Common Stock		(334,699	)		(92,626	)		(464,193	)		(265,795	)
Exercise of stock options		7,084			5,001			49,625			36,767
Payment of stock-based restricted and performance shares		9,273			11,376			167,315			89,666
Shares tendered for taxes on stock-based compensation		(3,565	)		(4,437	)		(79,035	)		(42,410	)
Other		-			-			6,563			7,709
Outstanding at end of period		65,154,082			65,298,085			65,154,082			65,298,085